MedPath

Use of the Quantra QPlus Sytem in Cardiac Surgery

Completed
Conditions
Cardiovascular Diseases
Interventions
Diagnostic Test: Quantra QPlus System
Registration Number
NCT05501730
Lead Sponsor
HemoSonics LLC
Brief Summary

Single center retrospective study evaluating the impact of using the Quantra QPlus System to guide transfusion decisions on postoperative outcomes in patients undergoing cardiac surgery.

Detailed Description

Yavapai Regional Medical Center (YRMC) implemented the Quantra QPlus System to aid in their efforts to effectively reduce the transfusion rate of allogenic blood products and improve outcomes in patients undergoing cardiac surgery. Use of the Quantra to guide decisions related to the use of blood products in cardiac surgery patients began in 2019. In this retrospective study, YRMC evaluated the impact of using the Quantra QPlus System to guide transfusion decisions on postoperative outcomes in patients undergoing cardiac surgery.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
128
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Post-QuantraQuantra QPlus SystemPatients undergoing cardiac surgery after the introduction of the Quantra.
Primary Outcome Measures
NameTimeMethod
Blood product utilizationPostoperative - after surgery throughout the rest of the hospital stay, assessed up to 30 days

Units of blood products administered to patient

Cost of blood productsThroughout the entire hospital stay, assessed up to 30 days

Total cost of blood products administered to patient

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Yavapai Regional Medical Center

🇺🇸

Prescott, Arizona, United States

© Copyright 2025. All Rights Reserved by MedPath